- Current report filing (8-K)
30 6월 2009 - 9:30PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities
Exchange Act of 1934
Date of Report
(Date of earliest event reported):
June 24, 2009
BIOPURE CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
DELAWARE
|
|
000-15167
|
|
04-2836871
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
11 HURLEY STREET
CAMBRIDGE, MA 02141
(Address of principal executive offices and zip code)
(617) 234-6500
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(d))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
ITEM 3.01.
|
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
.
|
On June 24, 2009, Biopure Corporation (the Company) received notice from The Nasdaq Stock Market (Nasdaq) stating that the
Company no longer meets the minimum of $2,500,000 in stockholders equity for continued listing on the Nasdaq Capital Market under Marketplace Rule 5550(b)(1). This notification has no effect on the listing of the Companys common stock at
this time.
Under the Marketplace Rule 5810(c)(2)(C), the Company has 15 calendar days to submit a plan to regain compliance. If such plan
is accepted, Nasdaq may grant an extension of up to 105 days from the date of notification to regain compliance. If the Company is unable to regain compliance its common stock will be delisted.
The Company does not currently intend to submit a plan to regain compliance.
On June 30, 2009, the Company issued a press release announcing its receipt of the Nasdaqs notification. A copy of the press release is being
furnished as Exhibit 99.1 to this report and is incorporated herein by reference.
ITEM 9.01.
|
Financial Statements and Exhibits
.
|
|
|
|
99.1
|
|
Press Release issued by the Company on June 30, 2009
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
BIOPURE CORPORATION
|
|
|
|
Date: June 30, 2009
|
|
By:
|
|
/s/ Zafiris G. Zafirelis
|
|
|
|
|
Zafiris G. Zafirelis
|
|
|
|
|
President and Chief Financial Officer
|
EXHIBIT INDEX
|
|
|
Exhibit
Number
|
|
Description
|
99.1
|
|
Press Release issued by Biopure Corporation on June 30, 2009
|
Biopure (MM) (NASDAQ:BPUR)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Biopure (MM) (NASDAQ:BPUR)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Biopure (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More News Articles